Interestingly, they are also further ahead on several important fronts they'll need to keep this moving forward. They have had an extra four months to prepare the Phase III trial protocols and to line up extra test sites. They have been working with Quinteles on the automation process gearing up for large scale mass use of Cypath. Also, they have started prepping Cypath for testing on other types of cancer. Plus, any University or Government funding deals they might have lined up based off good Phase II results. Everything could happen one right after the other....All triggered by release of PII results later this month.